PURR.AI
PrivateLast Round
Grant
Sep 15, 2025
Total Funding Raised
$135,000
Company Overview
PURR.AI is a biotechnology company that develops artificial intelligence solutions for targeted drug discovery, with a focus on neurotherapies and peptide design for age-related neurological disorders.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting, Subscription SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
PURR.AI Comparables
Compare PURR.AI with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Pepticom | 78% | |
| Manifold Bio | 77% | |
| Insilico Medicine | 74% | |
PURR.AI Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Sep 15, 2025 | ||||
| Accelerator | Feb 28, 2025 |
PURR.AI Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| ESA BIC Portugal | Accelerator |
| Startup Wise Guys | Accelerator |
| EmpoWomen | Accelerator |
| IAPMEI - Agência para a Competitividade e Inovação, I.P. | Grant |
PURR.AI Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about PURR.AI's valuation, stock price, and market status.